Products for Research Use Only
RegisterLogin

Visugromab

CAT: 0804-HY-P99100-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99100-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Visugromab (CTL-002) is a GDF-15 neutralizing IgG4 mAb. Visugromab has synergistic anticancer activity with the anti-PD1 antibody Nivolumab and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors. Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
CAS Number
2556646-63-8
Product Name Alternative
CTL-002
UNSPSC
12352203
Target
PD-1/PD-L1; TGF-beta/Smad
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/visugromab.html
Purity
98.40
Solubility
10 mM in DMSO|H2O
Smiles
[Visugromab]
Molecular Weight
(144.56 kDa)
References & Citations
[1]Necchi A, et al. Neutralizing GDF-15 in muscle-invasive bladder cancer (MIBC) : A neoadjuvant immunotherapy trial of visugromab (CTL-002) in combination with the anti-PD1 antibody nivolumab (NEO-GDFATHER) [J]. 2023.|[2]Melero I, et al. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature. 2025 Jan;637 (8048) :1218-1227.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831842-01Visugromab
GTR18334357-01Visugromab Antibody
HV986026-01Research Grade Visugromab
E55B0896Visugromab (Reference antibody)
ICH5286-10mgVisugromab Biosimilar - Research Grade
A138253Visugromab Biosimilar (Monoclonal, IgG4)
GTR18697205-01Visugromab Human Monoclonal Antibody
GTR18780885-01(Visugromab) Biosimilar Reference Antibody
12-90372-50Anti-GDF15 (visugromab biosimilar) mAb
A135629Visugromab Biosimilar (Monoclonal, IgG4-kappa)

Popular Products